SS Innovations International (NASDAQ:SSII) Cut to “Sell” at Wall Street Zen

Wall Street Zen downgraded shares of SS Innovations International (NASDAQ:SSII – Free Report) from a hold rating to a sell rating in a research note released on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SS Innovations International in a research note on Thursday, October 15th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, the stock currently has a consensus rating of “Sell” and an average target price of $7.00.

View Our Latest Stock Analysis on SSII

SS Innovations International Trading Down 18.7%

NASDAQ:SSII opened at $1.35 on Friday. SS Innovations International has a 52 week low of $1.26 and a 52 week high of $6.79. The firm has a 50-day moving average price of $2.60 and a two-hundred day moving average price of $3.70.

Insider Buying and Selling

In related news, CEO Srivastava Sudhir sold 33,333 shares of the company’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $3.00, for a total value of $99,999.00. Following the transaction, the chief executive officer owned 108,520,928 shares in the company, valued at approximately $325,562,784. This represents a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Institutional Trading of SS Innovations International

Several hedge funds have recently made changes to their positions in SSII. Goldman Sachs Group Inc. purchased a new position in shares of SS Innovations International during the 3rd quarter valued at $38,000. 71 West Capital Partners purchased a new stake in SS Innovations International in the 3rd quarter worth about $596,000. Inspire Investing LLC increased its holdings in SS Innovations International by 19.7% in the 3rd quarter. Inspire Investing LLC now owns 223,053 shares of the company’s stock worth $665,000 after acquiring an additional 36,756 shares during the last quarter. Finally, Eversept Partners LP raised its stake in SS Innovations International by 46.2% in the 1st quarter. Eversept Partners LP now owns 110,157 shares of the company’s stock valued at $551,000 after acquiring an additional 34,799 shares during the period.

About SS Innovations International

(Get Free Report)

SS Innovations International is a medical technology company focused on developing and manufacturing surgical robotic systems. Its flagship product, the SSI Mantra, is a multi-arm platform designed to support surgeons during minimally invasive procedures. The company’s offerings include surgical instruments and related technologies, such as its SSI Mudra instruments, as well as training and support services for hospitals and clinicians. The SSI Mantra system is designed with features including a surgeon console and 3D visualization, and the company has also emphasized remote surgery and telementoring capabilities.

See Also

Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.